Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Indian J Chest Dis Allied Sci ; 54(3): 201-3, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23008931

RESUMEN

An intracardiac myxoma is the most common tumour of the heart with an estimated incidence of 0.5 per million population per year. Extensive calcification is rare in these tumours. We describe a rare case of a large left atrial myxoma, visible on the chest radiograph, with extensive calcification and osseous metaplasia.


Asunto(s)
Calcinosis/patología , Neoplasias Cardíacas/patología , Mixoma/patología , Femenino , Atrios Cardíacos , Neoplasias Cardíacas/cirugía , Humanos , Persona de Mediana Edad , Mixoma/cirugía , Osificación Heterotópica/patología
2.
J Obstet Gynaecol India ; 63(4): 273-8, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24431655

RESUMEN

OBJECTIVE: A prospective cohort study in a teaching hospital to assess the efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced carcinoma cervix. METHOD: Neoadjuvant chemotherapy in the form of cisplatin 75 mg/m(2) and paclitaxel 135 mg/m(2) on day 1 and repeated at 14 days' interval for up to a maximum of three courses. RESULTS: Neoadjuvant chemotherapy in cervical cancer was effective in the downstaging of the disease. Downstaging was observed in 19.23 % of patients after two cycles and in 50 % of patients after three cycle of NACT. Operability increases to 33.3 and 38.4 % after two and three cycles of NACT, respectively. Complete pathological response was observed in 37.5 % of patients after NACT. No significant adverse effect in the feasibility of surgery was observed. CONCLUSION: The present study showed that neoadjuvant chemotherapy was an effective and well-tolerated mode of therapy with significantly less morbidity and mortality.

3.
Gynecol Oncol Case Rep ; 2(3): 100-1, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-24371633

RESUMEN

► CA 125 is the most useful tumor marker for epithelial ovarian carcinoma. ► Very high serum CA 125 level does not necessarily indicate ovarian malignancy. ► Rapidly rising and persistent levels of CA 125 may be consistent with benign disease.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA